Skip to main content
GoodMoatv1.1
Sign in
ABT logo

ABT

CompareEarnings: May 31, 2026

Abbott Laboratories

Exchange: NYSESector: HealthcareIndustry: Medical Devices

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 122,000 colleagues serve people in more than 160 countries. Connect with us at abbott.com and on LinkedIn, Facebook, Instagram, X and YouTube. About Flatiron Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients' real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group. SOURCE Abbott

Did you know?

A large-cap company with a $178.9B market cap.

Current Price

$102.87

+0.48%

GoodMoat Value

$72.81

29.2% overvalued
Profile
Valuation (TTM)
Market Cap$178.88B
P/E27.42
EV$186.31B
P/B3.39
Shares Out1.74B
P/Sales4.04
Revenue$44.33B
EV/EBITDA15.14

Abbott Laboratories (ABT) Insider Trades

ABT Insider Trading Activity

Track insider trading transactions for Abbott Laboratories (ABT). Monitor recent buys, sells, and option exercises by officers, directors, and 10% beneficial owners. Insider trading activity can signal management confidence or concern about a stock's future prospects.

Current stock price: $102.87. Market cap: $178.88B. This page displays the most recent insider transactions for ABT, including the insider's name, title, transaction type (purchase, sale, or option exercise), number of shares, and total value. Filter transactions by type to focus on open-market purchases or sales.

Insider buying is often viewed as a bullish signal, as insiders are putting their own capital at risk. Conversely, large insider sales may warrant further investigation. Use GoodMoat's insider trading data alongside financial analysis, quality scores, and valuation tools for a comprehensive view of Abbott Laboratories's investment outlook.